Skip to content

Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy in Renal Calculi

Tip-flexible Semi-rigid Ureterorenoscope Versus Flexible Ureteroscopy for the Treatment of Renal Calculi < 3 cm - Efficacity Prospective Randomized Multicentre Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02426931
Enrollment
280
Registered
2015-04-27
Start date
2015-04-30
Completion date
2015-06-30
Last updated
2015-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Calculi

Keywords

retrograde intrarenal surgery, flexible ureteroscopy, renal calculi

Brief summary

This study evaluates the safety and efficacy of the novel tip-flexible semi-rigid ureterorenoscope for the treatment of renal calculi using a prospective, randomized multicentre trial design. Half of participants will receive retrograde intrarenal surgery using the tip-flexible semi-rigid ureterorenoscope, while the other half participants will receive retrograde intrarenal surgery using the classic flexible ureteroscope.

Detailed description

Retrograde intrarenal surgery using flexible ureteroscope has become the first-line treatment for renal calculi \< 3.0 cm and is recommended by the European Association of Urology due to its minimally-invasive nature and satisfactory result. However, some limitations still remain. Poor maneuverability, extra costs for the ureteral access sheath, and high device vulnerability still preclude flexible ureteroscopy from wider distribution. Recently, the investigators present a novel ureterorenoscope, which is composed of a retractable rigid sheath and a semi-rigid ureteroscope with a flexible part on the tip. When the flexible tip of the inner shaft maintains within the sheath, working in the rigid mode, the tip-flexible semi-rigid ureterorenoscope is capable of passing either the orifice or the physiological tortuosity of the ureter with ease. When the inner shaft is extended beyond the sheath, the endoscope is switched to the flexible mode, capable of performing an intrarenal approach. This endoscope integrates the classic semi-rigid and flexible ureteroscope both structurally and functionally, and has been approved for clinical application by the China Food and Drug Administration. In this study, transverse comparison is designed to evaluate the safety and efficacy of the tip-flexible semi-rigid ureterorenoscope for the treatment of renal calculi.

Interventions

DEVICEthe tip-flexible ureterorenoscope

Ureteroscopy will be conducted using the tip-flexible semi-rigid ureterorenoscope to treat renal calculi. Holmium laser and basket can be used to perform the technique.

DEVICEthe classic flexible ureteroscope

Ureteroscopy will be conducted using the classic flexible ureteroscope (Flex x2 STORZ, Germany) to treat renal calculi. Holmium laser and basket can be used to perform the technique.

Sponsors

Changhai Hospital
CollaboratorOTHER
The First Affiliated Hospital of Guangzhou Medical University
CollaboratorOTHER
Xiangya Hospital of Central South University
CollaboratorOTHER
Ningbo No. 1 Hospital
CollaboratorOTHER
West China Hospital
CollaboratorOTHER
Beijing Tsinghua Changgeng Hospital
CollaboratorOTHER
Yantai Yuhuangding Hospital
CollaboratorOTHER
Ling Li, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Subject has provided informed consent and indicated a willingness to comply with study treatments * Subject has a diagnosis of renal stones according to computer tomography (CT) and intravenous pyelogram (IVP) results * Subject is a surgical candidate for the ureteroscopic approach * Subject is 18-80 yrs of age * Subject has a single stone \< 3 cm in size (IVP), or multiple stones \< 3 cm in cumulative size (IVP) * Subject has a serum creatinine level within the normal range for the study center

Exclusion criteria

* Subject needs bilateral procedures within one-stage ureteroscopy * Subject has an active urinary tract infection (e.g., cystitis, prostatitis, urethritis, etc.) * Subject has been diagnosed with a urethral stricture or bladder neck contracture * Subject has been diagnosed with a urinary tract infection related to stone obstruction within two weeks * Subject has severe hematuria that might blur the vision of the endoscopy * Subject has a disorder of the coagulation cascade system that would put the subject at risk for intraoperative or postoperative bleeding * Subject is unable to discontinue anticoagulant and antiplatelet therapy preoperatively (3-5 d) * Subject has other diseases and could not tolerate the endoscopic surgery * Subject has any kind of anatomic abnormality of the urinary system that might have an influence on the surgery * Subject has ipsilateral pre-stenting or previous ureteroscopy within six months * Subject has been diagnosed with hydronephrosis larger than 3 cm according to the B-scan ultrasonography examination

Design outcomes

Primary

MeasureTime frameDescription
Stone clearance12 weeks post-operativelyNumber of participants undergo tf-URS or f-URS surgeries without residual calculus/Total number of participants in each group \*100%

Secondary

MeasureTime frameDescription
Stone clearanceOne day post-operativelyNumber of participants undergo tf-URS or f-URS surgeries without residual calculus/Total number of participants in each group \*100%
Complication ratesWithin 12 weeks after surgeryNumber of participants undergo tf-URS or f-URS surgeries suffer complications associated with the surgery (i.e. painess(NRS≥4), hematuria, T≥38℃, serum WBC≥12×〖10〗\^9/L ,serum WBC\<4×〖10〗\^9/L, perforation, etc.)/Total number of participants in each group \*100%
Endoscope deflection loss ratesintraoperativeNumber of the broken novel ureterorenoscope or the broken classic flexible ureterosocpe with deflection loss\>10%/Total number of ureterorenoscope or ureterosocpe used \*100%
Endoscope Leakage ratesintraoperativeNumber of the broken novel ureterorenoscope or the broken classic flexible ureterosocpe with leakage of the working channel or the outer shaft/times of the ureterorenoscope or ureterosocpe used \*100%
Endoscope black dots ratesintraoperativeNumber of the broken novel ureterorenoscope or the broken classic flexible ureterosocpe with black dots on endoscopic images/times of ureterorenoscope or ureterosocpe used \*100%

Contacts

Primary ContactLing Li, MD
ejdll@163.com086-18019766513
Backup ContactYonghan Peng, MD
yonghanyhtl@163.com086-13917386896

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026